Old Web
English
Sign In
Acemap
>
authorDetail
>
João Paulo Duprat
João Paulo Duprat
Macular degeneration
Choroidal neovascularization
Ophthalmology
Medicine
Bevacizumab
4
Papers
145
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
2009
Retina-the Journal of Retinal and Vitreous Diseases
Marcos Pereira de Ávila
Michel Eid Farah
Arturo Santos
Ziya Kapran
João Paulo Duprat
Benjamin W. Woodward
Jeffrey Nau
Show All
Source
Cite
Save
Citations (50)
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration
2009
British Journal of Ophthalmology
Marcos Pereira de Ávila
Michel Eid Farah
Arturo Santos
João Paulo Duprat
Benjamin W. Woodward
Jeff Nau
Show All
Source
Cite
Save
Citations (70)
Morphologic and Clinical Effects of Subretinal Injection of Indocyanine Green and Infracyanine Green in Rabbits
2008
Journal of Ocular Pharmacology and Therapeutics
Fernando M. Penha
Mauricio Maia
Michel Eid Farah
Eduardo Dib
André H. Príncipe
Fracois Devin
Eduardo B. Rodrigues
João Paulo Duprat
Edna Freymüller
Show All
Source
Cite
Save
Citations (24)
A Study to Evaluate the Safety and Feasibility of Radiotherapy and Bevacizumab (Avastin) for the Treatment of Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration
2007
Investigative Ophthalmology & Visual Science
Elias Reichel
Michel Eid Farah
João Paulo Duprat
Marcos Pereira de Ávila
G.Y. Fujii
J.V. Rossi
Arturo Santos
Benjamin W. Woodward
M. Yaqub
Jeffrey Nau
Show All
Source
Cite
Save
Citations (1)
1